Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice
about
Identification of a hierarchy of multipotent hematopoietic progenitors in human cord bloodIsolation, growth and identification of colony-forming cells with erythroid, myeloid, dendritic cell and NK-cell potential from human fetal liverUpdate on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunitiesPhenotypic, Morphological and Adhesive Differences of Human Hematopoietic Progenitor Cells Cultured on Murine versus Human Mesenchymal Stromal Cells.Expansion of cord blood CD34 cells in presence of zVADfmk and zLLYfmk improved their in vitro functionality and in vivo engraftment in NOD/SCID mouseCD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells.Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor.Mouse models with human immunity and their application in biomedical research.Do hematopoietic cells exposed to a neurogenic environment mimic properties of endogenous neural precursors?Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation.Efficient marking of human cells with rapid but transient repopulating activity in autografted recipientsHuman and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers.Novel source of human hematopoietic stem cells from peritoneal dialysis effluents.Acute myeloid leukemia stem cells.Changes in the proliferative activity of human hematopoietic stem cells in NOD/SCID mice and enhancement of their transplantability after in vivo treatment with cell cycle inhibitorsAngiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantationHomology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.Mesenchymal stem cells in ex vivo cord blood expansion.Ex vivo expansion of cord blood.Ex vivo expansion of functional human UCB-HSCs/HPCs by coculture with AFT024-hkirre cells.Cancer stem cells and cancer therapy.Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies.Recent advances in acute myeloid leukemia stem cell biologyB cell biology: an overview.Dimethyl Sulfoxide (DMSO) Increases Percentage of CXCR4(+) Hematopoietic Stem/Progenitor Cells, Their Responsiveness to an SDF-1 Gradient, Homing Capacities, and Survival.Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantationDifferent subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.GPI-80 defines self-renewal ability in hematopoietic stem cells during human developmentSuperior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells.Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.Biophysical differences between chronic myelogenous leukemic quiescent and proliferating stem/progenitor cells.Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse.Mesenchymal stem cells promote a primitive phenotype CD34+c-kit+ in human cord blood-derived hematopoietic stem cells during ex vivo expansion.CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells.Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.Phenotypic and functional reversal within the early human hematopoietic compartment.In vitro expanded cells contributing to rapid severe combined immunodeficient repopulation activity are CD34+38-33+90+45RA-.
P2860
Q24656265-4DBC6193-E95E-43C6-BC13-E0DDE6635C68Q24797377-A643D2BE-A135-4885-ABF0-E7DF35F171BEQ28071384-3C1F760C-9DD1-4ADF-A4B3-EF0A65E92FA9Q30670619-08D80CA2-0C5D-435A-92EE-D78E0D755569Q33680859-D2550334-8E90-45BF-8542-E2222CA81C68Q33732412-EC0E6F80-72D2-432F-B04C-3FBEAE4C6125Q33801849-BAA267D5-E51A-4958-9C1E-0CCE1CA89E48Q33822226-3211F847-7774-48B6-8723-F4905208FDB5Q33925745-1450EE6B-C0D9-463B-B4E7-971F71A405DBQ34590684-FC4EA6B7-D8FB-428A-A1A1-549A3945D2EBQ35225233-220DB6D4-1B4B-4FCA-A92E-64D20F1977B9Q35699176-3DD96600-D4D1-424A-BC1E-9D3FD6562BE2Q35847936-3F0A3F23-A99C-444D-80FA-E214D4E8B209Q35868339-482BB163-ACB8-4551-8C08-B3EA6F3EBC57Q36145514-E9E6535D-1E97-4D2B-8917-6B47DDBDC96EQ36164458-FF2E9834-13CF-4450-9E62-ECB25556E1ECQ36371439-A7586723-A8C3-4B81-A070-67E6D1E69DDFQ36508850-37C7F98F-5EB3-4339-AE30-BD1BB7594329Q36828138-78475CC6-50B8-4EF3-8D2E-21606378E053Q37247846-20F5E907-89E9-4D15-8E3C-2877E20F369FQ37607979-B4489003-1E24-4972-989A-0757BB8D2C44Q37639878-CA0947CD-63B2-4563-97A2-676D4D0EBA3AQ37841186-0AF89EDD-E39E-40E3-9630-ECBAB063B7A6Q37853939-30965ED3-A754-404D-9607-E181B9BFA542Q38003359-5B43EAFB-D1F5-41F7-9D2C-C5124732A582Q38196333-37769BCB-D21F-4CAB-992A-B25164CFC12EQ38837322-4CF38E00-98C2-4BD9-9AA1-56A29B2D1F7DQ39646815-610D4042-2B48-4CD1-B5D3-7F4A95529A65Q40450701-7A0CE49A-ABA0-42DE-9643-458A99028CEAQ41653162-7F6E71BC-B6A8-4E76-97FF-3BEE9480F54AQ42043867-E6268CEE-B8AE-44CA-A156-13E8F3DB83DAQ42160266-CC9CEB88-6548-4601-AD4A-76B9C592BDB5Q42741832-B6EA77A8-63CB-4D13-B40C-21727DEEB37AQ42756599-63504ACE-E287-4342-88B5-607F4FA56591Q43205359-024AC8A7-CE47-4A70-91C7-700EFB0A5106Q43488062-F31ECB8B-4F27-4046-841E-505710CF9572Q44026903-C6A1D729-83AC-4E00-A265-4F29F8E2E985Q45869288-4416CE5E-CFC9-41FC-8692-6AB493B69B2FQ47340007-43535A1D-ABB6-4AAC-B3C2-9700F3AF981CQ49073610-3445B370-FB2B-49A6-A170-B25BB2F4C9B3
P2860
Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@ast
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@en
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@en-gb
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@nl
type
label
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@ast
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@en
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@en-gb
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@nl
prefLabel
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@ast
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@en
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@en-gb
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@nl
P2860
P3181
P356
P1476
Differential long-term and mul ...... ransplanted into NOD/SCID mice
@en
P2093
Christopher J Hogan
Elizabeth J Shpall
P2860
P3181
P356
10.1073/PNAS.012336799
P407
P50
P577
2002-01-08T00:00:00Z